Hydroxyurea reduces the 50% inhibitory concentration of didanosine in HIV-infected cells.
Rana
K Z
KZ
Simmons
K A
KA
Dudley
M N
MN
D019380:Anti-HIV Agents / Q000494:pharmacology*; D002478:Cells, Cultured; D016049:Didanosine / Q000494:pharmacology*; D004357:Drug Synergism; D015658:HIV Infections / Q000821:virology; D015497:HIV-1 / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D006918:Hydroxyurea / Q000494:pharmacology*; D020128:Inhibitory Concentration 50; D019384:Nucleic Acid Synthesis Inhibitors / Q000494:pharmacology*; D013601:T-Lymphocytes
D019380:Anti-HIV Agents; D019384:Nucleic Acid Synthesis Inhibitors; D016049:Didanosine; D006918:Hydroxyurea